NutriBand Inc.
NTRB Nasdaq· Orthopedic, Prosthetic & Surgical Appliances & Supplies
Last close · Oct 26, 2026
$5.97
KIRA · Stoqly’s AI analyst, in plain words
- NutriBand Inc. had $2.0M of revenue in fiscal 2026, down 4.8% on the year before. Over five years, revenue changed +16.6% a year on average.
- Its operating margin was −408.4%, up 72.3 pts: of every 100 in sales, about −408 is left after running the business.
- NutriBand Inc. lost $8.2M in fiscal 2026.
- Free cash flow was −$5.1M in fiscal 2026, −252.4% of revenue.
Market cap
$72.6M
P/E
—
Revenue
$2.0M
Net income
−$8.2M
Free cash flow
−$5.1M
Operating margin
−408.4%
NutriBand Inc. in 30 seconds · fiscal 2026
Are sales growing?
−4.8%
No. Sales fell 4.8% last year.
Does it make a profit?
−404.1%
No. It lost money last year.
Does profit turn into cash?
−252.4%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 8
Weak. It passes 3 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What NutriBand Inc. does
No business description yet.
- Fiscal year ends
- January 31, 2026
- Latest annual report
- 10-K · Apr 29, 2026
- Legal name
- NutriBand Inc.
- CIK
- 0001676047
NutriBand Inc. · NTRB
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $1.4M | $2.1M | $2.1M | $2.1M | $2.0M |
| Revenue growth | 50.7% | 46.2% | 0.3% | 2.6% | −4.8% |
| Gross margin | 39.0% | 36.1% | 41.3% | 34.7% | 27.8% |
| Operating margin | −429.7% | −215.2% | −233.6% | −480.7% | −408.4% |
| Net income | −$6.2M | −$4.5M | −$5.5M | −$10.5M | −$8.2M |
| Net margin | −434.3% | −215.6% | −263.0% | −490.0% | −404.1% |
| Diluted EPS | −$0.80 | −$0.53 | −$0.69 | −$0.99 | −$2.58 |
| Cash | |||||
| Cash from operations | −$2.8M | −$3.0M | −$3.5M | −$4.6M | −$5.1M |
| Capital expenditure | $0.1M | $0.1M | $0.1M | $0.1M | $0.0M |
| Free cash flow | −$2.9M | −$3.1M | −$3.6M | −$4.7M | −$5.1M |
| FCF margin | −203.3% | −147.5% | −171.6% | −220.5% | −252.4% |
| Share count change | 37.5% | 6.6% | −6.0% | 33.4% | 9.7% |
| Debt and strength | |||||
| Cash and short-term investments | $4.9M | $2.0M | $0.5M | $4.3M | $4.6M |
| Debt incl. finance leases | — | — | $2.0M | — | — |
| Loans, net | $0.1M | — | — | — | — |
| Deposits | $0.3M | $0.3M | — | — | — |
| Shareholders' equity | $11.9M | $8.6M | $6.4M | $6.4M | $6.7M |
| Current ratio | 7.0x | 3.6x | 1.0x | 4.9x | 6.4x |
| Interest coverage | −51.6x | −539.2x | −64.3x | −480.6x | −369.7x |
| Returns and quality | |||||
| Return on capital | — | — | −48.4% | — | — |
| Return on equity | −65.1% | −43.9% | −73.1% | −162.9% | −125.6% |
| Return on tangible equity | −114.1% | −161.8% | −732.2% | −235.7% | −631.2% |
| Piotroski F-score | 4 | 3 | 4 | 3 | 3 |
| Altman Z'' | 8.7 | 0.6 | −10.2 | −16.2 | −15.8 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
NutriBand Inc. · NTRB
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $5.97 a share, the company is worth $72.6M.
Source: SEC EDGAR XBRL filings (CIK 0001676047). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.